• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抑郁症的持续性如何影响医疗保险的连续性、类型以及心理健康治疗的覆盖范围限制?

How does the persistence of depression influence the continuity and type of health insurance and coverage limits on mental health therapy?

作者信息

Masaquel Anthony, Wells Kenneth, Ettner Susan L

机构信息

Department of Health Services, UCLA School of Public Health, Los Angeles, CA, USA.

出版信息

J Ment Health Policy Econ. 2007 Sep;10(3):133-44.

PMID:17890830
Abstract

AIM OF THE STUDY

To determine the structural effect of the persistence of depression on continuity and type of health insurance and coverage limits on mental health therapy.

METHODS

Data came from the Partners in Care study (PIC), a randomized controlled trial examining the effect of quality improvement (QI) programs involving medication or psychotherapy on the outcomes of initially depressed patients in seven managed care settings. The sample included approximately 945 adult patients under the age of 63 years who were primarily depressed and insured at baseline. Single-equation multivariate probit regressions were estimated to determine the association of depression burden days aggregated over the 6 to 24-month period post-baseline with the following dichotomous outcomes: continuous health insurance over 6 to 24 months; continuous private health insurance over 6 to 24 months; any public health insurance over 6 to 24 months; and reporting no insurance limits on mental health therapy coverage at 24 months. Other control variables included baseline insurance status, age, sex, race, marital status, education, income, assets, fixed site effects, and (in sensitivity analyses) number of medical comorbidities, alcohol use and drug use. To address the possibility of endogeneity bias in the relationship between depression and insurance, consistent estimates were derived from instrumental variables (IV) probit regressions and the endogeneity of depression burden days was tested. Potential instruments included the random assignment to intervention and control groups in the PIC study, type of depression at baseline, and baseline Mental Component Summary (MCS) score from the Short Form-12 (SF-12). In sensitivity analyses, data pooled (rather than aggregated) across waves were used to estimate probit and IV probit regressions, using Generalized Estimating Equations methods to adjust for within-person correlation of the error terms.

RESULTS

Evidence was found that depression burden days were exogenous to all of the health insurance outcomes except for coverage limits on mental health therapy. Based on the appropriate estimates (single-equation if exogenous, IV if endogenous), depression burden days appeared to increase the probability of having any public health insurance coverage and decrease the probability of having no coverage limits on mental health therapy. However, these effects were small in magnitude.

CONCLUSIONS

Reverse causality may be more of a concern when examining the influence of depression on mental health care coverage than on health insurance in general. Consistent with the government's historical role in financing mental health services, patients whose depression persisted to a greater extent were slightly more likely to have some public health insurance during an 18-month follow-up period. Furthermore, they were slightly more likely to have limits on mental health therapy coverage, suggesting that insurers may be more likely to control access at the level of the benefits structure than at the level of insurance coverage per se. Future analyses should examine the mediating factors in the relationship between depression and limits on mental health therapy coverage, e.g., diminished employment opportunities with large companies that offer more generous benefits.

摘要

研究目的

确定抑郁症持续存在对医疗保险的连续性、类型以及心理健康治疗覆盖范围限制的结构影响。

方法

数据来自“关爱伙伴研究”(PIC),这是一项随机对照试验,研究涉及药物治疗或心理治疗的质量改进(QI)项目对七个管理式医疗环境中初发抑郁症患者结局的影响。样本包括约945名63岁以下的成年患者,他们在基线时主要患有抑郁症且有保险。估计单方程多元概率回归,以确定基线后6至24个月内汇总的抑郁症负担天数与以下二分结局之间的关联:6至24个月的连续医疗保险;6至24个月的连续私人医疗保险;6至24个月的任何公共医疗保险;以及在24个月时报告心理健康治疗覆盖无保险限制。其他控制变量包括基线保险状况、年龄、性别、种族、婚姻状况、教育程度、收入、资产、固定地点效应,以及(在敏感性分析中)医疗合并症数量、酒精使用和药物使用情况。为解决抑郁症与保险之间关系中可能存在的内生性偏差问题,从工具变量(IV)概率回归中得出一致估计,并对抑郁症负担天数的内生性进行了检验。潜在工具变量包括PIC研究中干预组和对照组的随机分配、基线时的抑郁症类型,以及简式12项健康调查(SF - 12)的基线心理成分总结(MCS)得分。在敏感性分析中,使用跨波合并(而非汇总)的数据来估计概率回归和IV概率回归,采用广义估计方程方法来调整误差项的个体内相关性。

结果

发现除心理健康治疗覆盖范围限制外,抑郁症负担天数对于所有医疗保险结局而言是外生的。根据适当的估计(如果是外生的则用单方程,如果是内生的则用IV),抑郁症负担天数似乎增加了拥有任何公共医疗保险覆盖的概率,并降低了心理健康治疗覆盖无限制的概率。然而,这些影响的幅度较小。

结论

在研究抑郁症对心理健康护理覆盖范围的影响时,反向因果关系可能比研究其对一般医疗保险的影响更值得关注。与政府在为心理健康服务提供资金方面的历史作用一致,在18个月的随访期内,抑郁症持续程度较高的患者更有可能拥有某种公共医疗保险。此外,他们更有可能面临心理健康治疗覆盖范围的限制,这表明保险公司可能更倾向于在福利结构层面而非保险覆盖本身层面控制获取机会。未来的分析应研究抑郁症与心理健康治疗覆盖范围限制之间关系的中介因素,例如在提供更优厚福利的大公司就业机会减少的情况。

相似文献

1
How does the persistence of depression influence the continuity and type of health insurance and coverage limits on mental health therapy?抑郁症的持续性如何影响医疗保险的连续性、类型以及心理健康治疗的覆盖范围限制?
J Ment Health Policy Econ. 2007 Sep;10(3):133-44.
2
Labor Supply of Poor Residents in Metropolitan Miami, Florida: The Role of Depression and the Co-Morbid Effects of Substance Use.佛罗里达州迈阿密大都市贫困居民的劳动力供给:抑郁症的作用及物质使用的共病影响
J Ment Health Policy Econ. 2001 Dec 1;4(4):161-173.
3
Access to care and utilization among children: estimating the effects of public and private coverage.儿童获得医疗服务及利用情况:评估公共和私人医保覆盖的影响
Med Care. 2006 May;44(5 Suppl):I19-26. doi: 10.1097/01.mlr.0000208137.46917.3b.
4
Disability benefit coverage and program interactions in the working-age population.劳动年龄人口的残疾福利覆盖范围及项目互动
Soc Secur Bull. 2008;68(1):1-30.
5
Uninsured status and out-of-pocket costs at midlife.中年时的未参保状态与自付费用
Health Serv Res. 2000 Dec;35(5 Pt 1):911-32.
6
Insurance coverage and the treatment of mental illness: effect on medication and provider use.保险覆盖范围与精神疾病治疗:对药物使用和医疗服务提供者利用的影响。
J Ment Health Policy Econ. 2008 Dec;11(4):177-99.
7
Labor market, financial, insurance and disability outcomes among near elderly Americans with depression and pain.患有抑郁症和疼痛的美国临近老年人的劳动力市场、金融、保险及残疾状况
J Ment Health Policy Econ. 2005 Dec;8(4):219-28.
8
Health insurance and health at age 65: implications for medical care spending on new Medicare beneficiaries.医疗保险与65岁时的健康状况:对新加入医疗保险者医疗支出的影响。
Health Serv Res. 2006 Apr;41(2):429-51. doi: 10.1111/j.1475-6773.2005.00491.x.
9
The cumulative effects of quality improvement for depression on outcome disparities over 9 years: results from a randomized, controlled group-level trial.9年期间抑郁症质量改善对结局差异的累积影响:一项随机对照群组水平试验的结果
Med Care. 2007 Nov;45(11):1052-9. doi: 10.1097/MLR.0b013e31813797e5.
10
Eurythmy therapy in chronic disease: a four-year prospective cohort study.慢性疾病中的韵律治疗:一项为期四年的前瞻性队列研究。
BMC Public Health. 2007 Apr 23;7:61. doi: 10.1186/1471-2458-7-61.

引用本文的文献

1
Collaborative care for depression and anxiety problems.抑郁症和焦虑症的协作护理。
Cochrane Database Syst Rev. 2012 Oct 17;10(10):CD006525. doi: 10.1002/14651858.CD006525.pub2.